Medtronic plc, a leader in medical technology, has seen varying analyst recommendations over recent months, reflecting market sentiment trends. The company shows a strong performance in the cardiovascular and medical surgical markets, which is mirrored in the overall positive analyst ratings, with a considerable number of 'Buy' and 'Hold' recommendations. Current trends suggest cautious optimism with a stable outlook, avoiding extreme ratings like 'Strong Sell'.
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 4 | |
| Buy | 13 | |
| Hold | 15 | |
| Sell | 0 | |
| Strong Sell | 0 |
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-09 | Outperform | Outperform | Bernstein |
| 2026-01-08 | Overweight | Overweight | Barclays |
| 2026-01-06 | Outperform | Market Perform | William Blair |
| 2025-12-18 | Hold | Hold | Truist Securities |
| 2025-11-20 | Hold | Hold | Truist Securities |
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-06 | Outperform | Market Perform | William Blair |
| 2025-11-19 | Neutral | Sell | Goldman Sachs |
| 2025-06-30 | Peer Perform | Underperform | Wolfe Research |
| 2025-03-04 | Buy | Neutral | Citigroup |
| 2024-10-10 | Outperform | Sector Perform | RBC Capital |